| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |